Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SNSE
SNSE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SNSE News
Sensei Biotherapeutics Rebrands as Faeth Therapeutics
5d ago
seekingalpha
Biotech Company Movements Analysis
5d ago
NASDAQ.COM
Latest Wall Street Ratings Overview
Jun 11 2026
CNBC
Replimune Receives FDA Support for BLA Resubmission
Jun 01 2026
NASDAQ.COM
Sensei Biotherapeutics Reports Significant Q1 Losses Amid Pipeline Developments
May 19 2026
NASDAQ.COM
Sensei Biotherapeutics Reports Q1 2026 Financial Results and Clinical Updates
May 15 2026
Newsfilter
GT Biopharma Initiates Phase 1 Trial of GTB-5550 for Solid Tumors
May 14 2026
Newsfilter
Sensei Biotherapeutics Launches PIKTOR Clinical Trial for Advanced Breast Cancer
May 05 2026
Newsfilter
SENSEI Biotherapeutics Administers First Dose to Patient in Phase 1B/2 Trial of PIKTOR for HR+/HER2- Advanced Breast Cancer
May 05 2026
moomoo
Surge in Short Selling of Small-Cap Healthcare Stocks
May 04 2026
seekingalpha
Sensei Biotherapeutics Reports Increased Losses in FY Earnings
Mar 30 2026
seekingalpha
Biotech Investment Revives as Institutional Capital Flows Back
Mar 19 2026
Globenewswire
Sensei Biotherapeutics Grants Stock Options to New Employee
Mar 17 2026
Newsfilter
Sensei Biotherapeutics Grants Stock Options to New Employees
Feb 25 2026
Newsfilter
Sensei Biotherapeutics Secures $200 Million Financing and Acquires Faeth
Feb 18 2026
stocktwits
U.S. Stocks Rise, Nasdaq Gains Over 1%
Feb 18 2026
Benzinga
Show More News
